We would love to hear your thoughts about our site and services, please take our survey here.
Storm in a tea cup…let’s focus on modi delivering an outstanding result … and for an overseas offer baked with the help of our big investors which potentially will take the new platform across the pond. Somehow don’t rely on UK gov to take a sensible direction.
Partnership to develop vaccine based on mRNA tech, that doesn’t inspire with confidence that SC are somehow part of this initiative. Puzzling as if the ongoing trial is being pushed aside. Doesn’t make sense and to be honest I don’t know what to make of the news. Next RNS may give some clarity, but more important is to have outstanding outcome from the trial.
Well mark, great for holding on. I probably would have sold 10 time if I jumped in 10 years ago. Great if you had the chance to accumulate on dips, regardless we hope for at least 10 X from where we are at present. Wish you happy and healthy new year.
Indeed. IMHO, GSK are not remotely close to the to get a platform/product where development cycle is almost done. with SC, we are all waiting for the official update. If it does what is written on the tin, then it’s exactly in line with GSK criteria. However the price should be significantly higher. Happy and healthy 2023.
Luke Miles said GSK was not trying to beat the biggest players in oncology. Instead, the company was focusing its oncology business on creating drugs for seriously ill patients who do not respond to other treatments, in a “salvage strategy”.
And all of that for 1-2 billion USD… he is having a laugh ?
Personally, I have my doubt regarding update this side of year. Taking into account the possible time table for events corresponding to all cohort participants, it seems more likely to get a comprehensive update in jan 2023. ATVB.
Hey defender, where have you been all this time. You converse with so much conviction as if you have an open line to all pharma CEO. Make sure you take your prescription medication on time.